Advertisement
Advertisement

OCEA

OCEA logo

Ocean Biomedical Inc.

0.6
USD
-0.026
-4.15%
Dec 18, 13:11 UTC -5
Closed
...

Ocean Biomedical Inc. Profile

About

Ocean Biomedical Inc. is a biopharma company which involved in development and commercialization of scientifically compelling assets. Its core portfolio is focused on oncology, pulmonary fibrosis and infectious disease. Ocean Biomedical Inc., formerly known as Aesther Healthcare Acquisitions Corp., is based in NEW YORK.

Info & Links

CEO

Elizabeth Ng

Headquarters

55 Claverick St., Room 325
Providence, RI 02903, UNITED STATES

Auditor

MaloneBailey, LLP

Share holders

57

Employees

9

Ocean Biomedical Inc. Statistics

Valuation Measures

Market Capitalization2

20.89M

Enterprise Value

31.91M

Enterprise Value/EBITDA(ttm)

17.46

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

--

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

--

Return on Invested Capital(ttm)

187.51%

Return on Assets(ttm)

--

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

1.83M

Net Income Available to Common(ttm)

-82.19M

Diluted EPS(ttm)

--

Share Statistics

Beta (5Y Monthly)

1.38

52-Week Change

-26.78%

S&P 500 52-Week Change

23.87%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

34.15M

Dividend Yield

0.00%

Float4

9.23M

% Held by Insiders

73.50%

% Held by Institutions

24.55%

Balance Sheet

Total Cash(mrq)

1.03M

Total Cash Per Share(mrq)

0.03

Total Debt(mrq)

12.05M

Total Debt/Equity(mrq)

-13.35%

Current Ratio(mrq)

0.07%

Quick Ratio(mrq)

--

Book Value Per Share(mrq)

-2.62

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.36

Free Cash Flow(ytd)

-9.43M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement